Privacy Policy
Signals Blog

Contributors

Categories

Revolution and reimbursement in the cell therapy industry

. With contributions from James Smith, a recent Oxford University graduate and current CASMI Translational Stem Cell Consortium Research Associate   In the early 1770s, Britain faced a significant financial dilemma. One of its most important commercial institutions,...

Right Turn: Seeing the potential of retinal stem cells

> The well known expression that “the eyes are the gateway to the soul” has tragic connotations in the context of retinal disease. Rhetoric aside, the potential for regenerative medicine to improve our ability to treat ocular disease and injury makes it an exciting...

Trainee talks – where you hear about the really cool stuff

> One of the consistent themes of the Till and McCulloch Meetings (#TMM2014) is its commitment to having students and postdocs on stage presenting their work. These sessions have been regularly cited by my colleagues as the most interesting and engaging sessions...

Using cell circuits to program cellular outcomes

> One of my favourite things about the Till and McCulloch Meetings (#TMM2014) is the careful thought that goes into session organization. The balance of basic science, ethics, engineering, and industrial and clinical applications has always been a nice feature of...

Right Turn: New StemCellShorts illuminates cancer stem cells

> Just over one year ago, we launched the pilot phase of an animation project titled StemCellShorts here on Signals blog. Funded by a Stem Cell Network Public Outreach Award, the project was very much an experiment for us to see what would happen when you tasked a...

What not to miss at #TMM2014

> Next week, close to 500 researchers, clinicians, trainees, industry and government representatives will gather in Ottawa for some of the best the stem cell and regenerative medicine research community has to offer. The third Till & McCulloch Meetings is...

Subscribe to Signals

Subscribe to our blog list to receive the latest news and updates.

You have Successfully Subscribed!